NEWS & INDUSTRY UPDATES
Clinical Trial Application Submitted to Health Canada for Experiential, Psychedelic-Assisted Psychotherapy Training
ATMA Journey Centers have applied for Health Canada approval to provide experiential training to mental health professionals interested in learning how to provide psychedelic-assisted psychotherapy.
As research continues & more data becomes available, we will deepen our understanding of the impact that psychedelics have in reducing the economic and health burden of mental health disorders.
ATMA Journey Centers Secures Supply Contract With Havn Life Sciences For GMP Grade Naturally-Derived Psilocybin On The Heels Of New Section 56 Exemptions
Supply agreement provides ATMA with a legal and reliable source of psilocybin to fuel its growth and expansion as a leader in therapy, experiential therapist training and facilitator of clinical trials